NCT03445117

Brief Summary

Pneumonia and influenza are among the top causes of hospitalisation and death in the elderly. While vaccinations are recommended against these diseases, a large proportion of elderly in the community remain unvaccinated, with approximately only 10% vaccinated for either disease. In this study, the investigators aim to implement an intervention package within GP clinics to increase influenza and pneumococcal vaccination rates, especially among elderly patients with chronic diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,837

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 26, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

July 5, 2019

Status Verified

June 1, 2019

Enrollment Period

9 months

First QC Date

January 28, 2018

Last Update Submit

July 1, 2019

Conditions

Keywords

Influenza VaccinesPneumococcal VaccinesPrimary Health CareHealth CommunicationCross-Over StudiesRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Difference in influenza vaccination uptake rate for clinics between intervention and non-intervention periods

    The proportion of all eligible patients arriving at each clinic who receive influenza vaccine during the intervention period compared to the non-intervention period for each clinic.

    8 months (post-study completion)

  • Difference in pneumococcal vaccination uptake rate for clinics between intervention and non-intervention periods

    The proportion of all eligible patients arriving at each clinic who receive pneumococcal vaccine during the intervention period compared to the non-intervention period for each clinic.

    8 months (post-study completion)

Study Arms (2)

Intervention

EXPERIMENTAL

Clinics assigned to the intervention arm will receive an educational intervention. This comprises posters on vaccination to be put up in the clinic, as well as a flyer which will be handed out by the clinic assistants to all patients 65 years and above, at the point of registration. The poster and flyer content will provide simple messaging to encourage patients to receive influenza and pneumococcal vaccinations and inform them of available healthcare subsidies.

Other: Educational intervention

Control

NO INTERVENTION

Clinics assigned to control arm will run as per their normal operations and not have the interventions implemented.

Interventions

a) The educational intervention comprises putting up posters on vaccination in the clinic, as well as provision of a specially designed flyer to the clinic, which will be handed out by the clinic assistants to all patients 65 years and above, at the point of registration. The poster and flyer content will provide simple messaging to encourage patients to receive influenza and pneumococcal vaccinations and inform them of available healthcare subsidies. b) Reminders to physicians: The flyers will also serve as physical prompts to physicians to encourage vaccination for their patients. Doctors and clinic staff will also be updated on the study protocol and the recommended adult vaccination schedule before commencement of the study.

Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients seen at GP clinics involved in our study AND
  • Aged 65 years and above, with or without chronic disease

You may not qualify if:

  • Patients not seen at GP clinics involved in our study
  • Patients aged below 65 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Frontier Healthcare Group

Singapore, 400305, Singapore

Location

OneCare Medical Group

Singapore, 609966, Singapore

Location

Related Publications (1)

  • Ho HJ, Tan YR, Cook AR, Koh G, Tham TY, Anwar E, Hui Chiang GS, Lwin MO, Chen MI. Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial. Am J Public Health. 2019 Dec;109(12):1776-1783. doi: 10.2105/AJPH.2019.305328. Epub 2019 Oct 17.

MeSH Terms

Conditions

Influenza, Human

Interventions

Early Intervention, Educational

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health Services

Study Officials

  • Dr Hanley Ho

    Tan Tock Seng Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: two-arm cluster randomised crossover trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2018

First Posted

February 26, 2018

Study Start

November 1, 2017

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

July 5, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations